Stock 8037 CHINA BIOTECH SERVICES HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News China Biotech Services Holdings Limited

Equities

8037

BMG2152F1014

Delayed Hong Kong S.E.
Other stock markets
 22:34:56 2024-05-13 EDT 		5-day change 1st Jan Change
0.375 HKD +1.35% Intraday chart for China Biotech Services Holdings Limited +25.42% -51.95%
03-28 China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023 CI
03-28 China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Biotech Services Holdings Limited announced that it expects to receive HKD 88 million in funding
CI
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
CI
Pengbo Medical Technology Co., Ltd. Announces the Approval by the Hainan Provincial Medical Products Administration for the Import of Medical Devices
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2023
CI
China Biotech Services Holdings Limited Announces Strategic Cooperation Framework Agreement with Astrazeneca Investment Co., Ltd
CI
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
China Biotech Services Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023
CI
China Biotech Services Holdings Limited Announces Redesignation of Chui Hoi Yam from an Executive Director to Non-Executive Director
CI
China Biotech Services Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022
CI
China Biotech Services Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
China Biotech Services Holdings Limited and The Chinese University of Hong Kong Enter into Memorandum of Understanding
CI
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Three Months Ended 31 March 2023
CI
China Biotech Services Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2022, Payable on 15 June 2023
CI
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022
CI
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
AQ
China Biotech Services Holdings Limited announced that it has received HKD 77.8 million in funding from Guoyuan Securities Investment (Hong Kong) Limited
CI
China Biotech Services Holdings Limited Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8037 Stock
  4. News China Biotech Services Holdings Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW